Complement C3 variant and the risk of age-related macular degeneration. - Wikidata - wikimedia - TriplyDB

Complement C3 variant and the risk of age-related macular degeneration.

Complement C3 variant and the risk of age-related macular degeneration.

http://www.wikidata.org/entity/Q34651682

about

CFH, C3 and ARMS2 are significant risk loci for susceptibility but not for disease progression of geographic atrophy due to AMD Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers Genetic variants near TIMP3 and high-density lipoprotein-associated loci influence susceptibility to age-related macular degeneration Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)Therapeutic targets in age-related macular disease Complement in age-related macular degeneration: a focus on function A global reference for human genetic variation AMD and the alternative complement pathway: genetics and functional implications Inflammation and its role in age-related macular degeneration Current therapeutic developments in atrophic age-related macular degeneration Management of neovascular age-related macular degeneration: current state-of-the-art care for optimizing visual outcomes and therapies in development Genetics of immunological and inflammatory components in age-related macular degeneration The complotype: dictating risk for inflammation and infection Complement system activation and endothelial dysfunction in patients with age-related macular degeneration (AMD): possible relationship between AMD and atherosclerosis The proteomics of drusen Animal models of age related macular degeneration Advances in the genomics of common eye diseases Genetic variants in the complement system predisposing to age-related macular degeneration: a review Alternative complement pathway deficiency ameliorates chronic smoke-induced functional and morphological ocular injury Systemic complement activation in age-related macular degeneration Association between the SERPING1 gene and age-related macular degeneration: a two-stage case-control study CEP biomarkers as potential tools for monitoring therapeutics Elevated high-density lipoprotein cholesterol and age-related macular degeneration: the Alienor study Complement gene variants in relation to autoantibodies to beta cell specific antigens and type 1 diabetes in the TEDDY Study.Using genetic variation and environmental risk factor data to identify individuals at high risk for age-related macular degeneration The ERCC6 gene and age-related macular degeneration Genetic factors in nonsmokers with age-related macular degeneration revealed through genome-wide gene-environment interaction analysis Heritability and genome-wide association study to assess genetic differences between advanced age-related macular degeneration subtypes Seven new loci associated with age-related macular degeneration.Genome-wide association study of age-related macular degeneration identifies associated variants in the TNXB-FKBPL-NOTCH4 region of chromosome 6p21.3 Homocysteine and risk of age-related macular degeneration: a systematic review and meta-analysis.A novel source of methylglyoxal and glyoxal in retina: implications for age-related macular degeneration AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice Complement factor H deficiency in aged mice causes retinal abnormalities and visual dysfunction.C2 and CFB genes in age-related maculopathy and joint action with CFH and LOC387715 genes.Genetic influences on plasma CFH and CFHR1 concentrations and their role in susceptibility to age-related macular degeneration Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome Complement factor H: using atomic resolution structure to illuminate disease mechanisms.Evaluation of clustering and genotype distribution for replication in genome wide association studies: the age-related eye disease study Multifactor effects and evidence of potential interaction between complement factor H Y402H and LOC387715 A69S in age-related macular degeneration.

P2860

200cd681211792c2c0d826f53aaa65af520b72ed

P248

Q21090046-6A1BE238-DCDE-4EB5-B419-AE55AD6869FB Q21563322-CA43B6DA-4DAB-49AC-A758-E03CD9E21872 Q24622351-D50824A0-5879-4613-BBB8-CFF8C570780A Q24622766-FE979D60-2CD0-4A98-8EAA-565FE15CB0AE Q24623107-83572902-E0F4-483E-8A10-96BE8954580D Q24635874-4395E638-8D57-4C07-985A-2F233D91CA30 Q25909434-131E590E-B41D-4CB3-94CD-AEDC16D2B534 Q26744106-6878CE50-3C1C-4AD9-A6C8-11C0EFAF9336 Q26768520-0AF01ECF-1BC8-4EC7-80DF-8A0812E4F3E0 Q26778247-F29EAC88-B0C9-418E-BB72-1D8D7DC140EC Q26824335-C6ECC3AE-9B51-4E70-AAE5-C3031C56D82C Q26849231-C282C745-1D03-4235-BB36-E6470CB0CE2F Q26862665-9663F735-6950-4BE1-8F0C-156068E69269 Q26862738-15C8A3A5-41EB-456D-A945-802CDC37491E Q26997523-8AAB993B-5CD5-4316-8953-077B80AC35A7 Q27004686-5541F175-5457-4EE6-A879-01BBAEF59D6C Q27008236-3F98FC41-A731-4ACC-B3F0-F40A581AC96F Q27021836-85351BA5-121B-4966-8A9E-46BF6FC42C38 Q27311630-42B912C4-83CD-4E7C-892F-B4B7F9CF650A Q28285925-90F02046-A670-43CF-9466-F91C481A48E9 Q28296326-2D03BC61-8F7B-4A68-8B44-63BBB4E52F1C Q28533972-812F29F9-FDEE-44F4-8962-78EA607DA5BE Q28540642-BB5E21F1-2BAE-4E14-9532-B6ED06140DA0 Q28601170-A778764E-0E11-46F6-89AE-8C529FFB0B43 Q28741677-129A689C-A02B-4DA0-BC98-DA9899921D3D Q28748643-D18E851E-863E-4657-A839-4DC4ACD0AB9A Q28943491-C1649D60-905D-4061-92D5-F6B9F871D10A Q28943546-8CB0AA22-C55B-49EB-A5E9-80FE40420EA9 Q29416998-5757EA07-B257-4D7A-ADCF-765451F34569 Q29417061-260F79FB-9A73-40B5-8249-9D191FEC9EF5 Q30240090-7D80D2B5-EC59-47FF-BB64-6AE4800E9887 Q31076669-D969FDC5-7FF9-4736-99A6-17D98380245E Q31154707-310A0B34-1DA8-41E6-9063-B200CCD256E4 Q33301870-F6431728-6CDC-4E72-81AF-07537449874B Q33336401-FA4D131E-442B-4525-82D6-2F9C77AA187F Q33356232-94820CD0-F59B-4BCA-BD74-3D85B0560D97 Q33381182-6901C2D1-427E-4082-A89D-5E3E5EFC712F Q33382097-839AAE1E-91FA-4151-9CB4-53C29DE74729 Q33388223-42D3798A-9283-4420-9384-72E4B0893AD0 Q33388699-D1D74A10-EFC3-4704-9E8F-6A43A0F0DF9D

P2860

Complement C3 variant and the risk of age-related macular degeneration.

http://www.wikidata.org/entity/Q34651682

description

2007 nî lūn-bûn

@nan

2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Complement C3 variant and the risk of age-related macular degeneration.

@ast

Complement C3 variant and the risk of age-related macular degeneration.

@en

Complement C3 variant and the risk of age-related macular degeneration.

@nl

type

label

Complement C3 variant and the risk of age-related macular degeneration.

@ast

Complement C3 variant and the risk of age-related macular degeneration.

@en

Complement C3 variant and the risk of age-related macular degeneration.

@nl

prefLabel

Complement C3 variant and the risk of age-related macular degeneration.

@ast

Complement C3 variant and the risk of age-related macular degeneration.

@en

Complement C3 variant and the risk of age-related macular degeneration.

@nl

P1433

Q34651682-70ACB86A-29AF-4A37-8390-A94D6E62A0EA

P1476

Q34651682-15B0165A-E4D9-4778-B1AB-FEBEA38847F6

P2093

Q34651682-2DEFB695-A69A-443D-8CFB-85375A008220

Q34651682-34FA2476-E9CF-4372-B849-851E4B54668E

Q34651682-3F6DB374-0B37-4FAF-B241-719B2C3FAD55

Q34651682-400D5062-ED89-462F-B879-725F1231E858

Q34651682-4202F8F6-845C-4F85-8BC9-71FEC8E97CBA

Q34651682-5403DE28-F6A7-4335-BA41-F02FC33B7B7B

Q34651682-56B868B4-9D58-4E00-9536-80D5084E7C80

Q34651682-5A8FE1A8-1567-44C2-8977-6F7F92936125

Q34651682-604D8309-0698-4C9D-833C-1F01ACB010A1

Q34651682-768E577C-D4F0-4E0C-8634-034900A98D75

P304

Q34651682-44ADF7C6-C600-41AB-9CAF-D4C4BB65E3D0

P31

Q34651682-8045A621-3B09-447E-AF8A-8900CE403144

P356

Q34651682-6F3AB992-D35E-4CD8-AC4D-2F1F5C683999

P407

Q34651682-0A6D1AD7-A310-46FC-BA8F-B2AC3B08A541

P433

Q34651682-5167873E-6430-4B46-BE3C-4D516317A520

P478

Q34651682-F70147E9-E23A-4918-BB39-7772C3750E13

P50

Q34651682-DAEA82F6-73A3-45A5-AA57-2372326DF680

P577

Q34651682-F194E7B6-4478-4E8D-9AFA-71ADF8D6024B

P698

Q34651682-EC4FEBE7-3A5E-4560-97AC-7D64D21A5F3C

P356

P1433

The New England Journal of Medicine

P1476

Complement C3 variant and the risk of age-related macular degeneration.

@en

P2093

Alan C Bird

http://www.w3.org/2001/XMLSchema#string

Alan F Wright

http://www.w3.org/2001/XMLSchema#string

Ana Maria Armbrecht

http://www.w3.org/2001/XMLSchema#string

Anthony T Moore

http://www.w3.org/2001/XMLSchema#string

Baljean Dhillon

http://www.w3.org/2001/XMLSchema#string

Baljinder K Matharu

http://www.w3.org/2001/XMLSchema#string

David G Clayton

http://www.w3.org/2001/XMLSchema#string

Deborah A Thurlby

http://www.w3.org/2001/XMLSchema#string

Elizabeth Redmond

http://www.w3.org/2001/XMLSchema#string

Genetic Factors in AMD Study Group

http://www.w3.org/2001/XMLSchema#string

P304

553-561

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA072618

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

357

http://www.w3.org/2001/XMLSchema#string

P50

Caroline Hayward

P577

2007-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17634448

http://www.w3.org/2001/XMLSchema#string